An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients - sprookjes - yvandenbroek - TriplyDB

An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients

An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients

http://www.wikidata.org/entity/Q28238050

about

Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and III Rasch analysis of clinical outcome measures in spinal muscular atrophy.Rasch analysis of the Pediatric Evaluation of Disability Inventory-computer adaptive test (PEDI-CAT) item bank for children and young adults with spinal muscular atrophy.Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy Adiposity is increased among high-functioning, non-ambulatory patients with spinal muscular atrophy Assessing spinal muscular atrophy with quantitative ultrasound.Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy.SMA-MAP: a plasma protein panel for spinal muscular atrophy Reliability of the Modified Hammersmith Functional Motor Scale in young children with spinal muscular atrophy.Reliability and validity of the TIMPSI for infants with spinal muscular atrophy type I The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): test development and reliability.Understanding the experiences and needs of individuals with Spinal Muscular Atrophy and their parents: a qualitative study Feasibility of Using Microsoft Kinect to Assess Upper Limb Movement in Type III Spinal Muscular Atrophy Patients.Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool.Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy.A qualitative study of perceptions of meaningful change in spinal muscular atrophy Prospective cohort study of spinal muscular atrophy types 2 and 3.Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials.Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy.Recent developments in the treatment of Duchenne muscular dystrophy and spinal muscular atrophy.Motor and cognitive assessment of infants and young boys with Duchenne Muscular Dystrophy: results from the Muscular Dystrophy Association DMD Clinical Research Network.Increased fat mass and high incidence of overweight despite low body mass index in patients with spinal muscular atrophy.Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year.Clinical outcome measures in spinal muscular atrophy.English cross-cultural translation and validation of the neuromuscular score: a system for motor function classification in patients with neuromuscular diseases Six-minute walk test is reliable and valid in spinal muscular atrophy.Thigh muscle volume measured by magnetic resonance imaging is stable over a 6-month interval in spinal muscular atrophy.Old measures and new scores in spinal muscular atrophy patients.Spinal muscular atrophy functional composite score: A functional measure in spinal muscular atrophy.Single-Blind, Randomized, Controlled Clinical Trial of Exercise in Ambulatory Spinal Muscular Atrophy: Why are the Results Negative?Correlation between motor performance scales, body composition, and anthropometry in patients with Duchenne muscular dystrophy.Making sense of antisense oligonucleotides: A narrative review.Correlates of health related quality of life in adult patients with spinal muscular atrophy.International Workshop:: Outcome measures and clinical trial readiness in primary mitochondrial myopathies in children and adults. Consensus recommendations. 16-18 November 2016, Rome, Italy.Muscle volume estimation by magnetic resonance imaging in spinal muscular atrophy.Aquatic therapy for a child with type III spinal muscular atrophy: a case report.Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening.Evaluator Training and Reliability for SMA Global Nusinersen Trials1.Vibration-Assisted Home Training Program for Children With Spinal Muscular Atrophy.Ambulatory function in spinal muscular atrophy: Age-related patterns of progression.

P2860

Q28248897-3591686B-4BA9-4A28-BBE7-E959E015A671 Q30407124-4F158EDF-B87F-4A17-8DE7-5EEF0052F3AE Q33458178-F1B51A0F-84EC-4C30-B82D-4C1CCB24725C Q33730357-AC5F922E-012B-41AA-B2CE-3DFC84AC0855 Q33988183-8EAF62DC-CE1A-4E98-A39A-4D68A63D6161 Q34053266-49F8CFCA-0D3B-407F-87AD-A845C38C0357 Q34540158-E7FDDEFC-A4F5-4D89-9515-ACF0870073DE Q34658131-47866B14-F8C1-4DF3-9632-D9512D2472BA Q35106119-65E7881E-128E-4306-AF4D-4F6E7B5B66D0 Q35238315-165E64B1-78E0-4CF6-BDB3-4A210B6715DF Q35677198-1DABEF5E-D36C-4B62-A12F-88AF8274D4D1 Q35820766-D631B4C8-E5E2-44A1-95ED-2DBF07238359 Q36259869-199E6853-BC90-4EFF-87BA-4DF9472F80BE Q36286233-83D5DE79-0A9B-4E5B-81F9-D603DA9F0F62 Q36288904-7FB81477-14A9-4810-9016-F65A99471A64 Q36334820-8353BCDB-5AEC-44B4-B629-4AA38E4D9B62 Q36475291-073706F5-1D4E-4693-91D4-9268BF60E07D Q36603337-0F6A8218-05D4-470E-86FE-4206CA0A9A9F Q36661721-A9ADAC39-CDCC-4ECB-8C96-1C74A6424FCB Q36761839-85C412FF-7084-4BF7-A070-74D2A9652E7E Q37095860-A19AC2F2-C640-4BF1-BB69-80803A40D059 Q37312480-5FD420F5-F43D-488F-B6C6-2C9B7911BEA7 Q37339701-47078E8B-75A5-4742-8EF6-811D5FF79F25 Q37513013-3058BC3F-B0F0-4784-8370-D41CD626628E Q37555721-62225527-86B5-4316-BEE2-DE07898401F0 Q38789047-BA8C165C-78F6-4856-920F-7570B822C3C9 Q39750156-3475F8F8-51B3-4E62-8BCA-A462EE939658 Q40796683-0B1D6980-46EC-45E7-AA20-C9BC083292AF Q41110966-65431EE3-7DB7-4680-B549-2AA318DD6B11 Q42002252-FA2405E5-7C13-42E8-BB0D-A0D49C48058B Q46053351-9D9E45B5-558E-4EE2-9B40-C9C899E2402B Q47438944-06351CAB-B99F-4CC3-BD83-9673BB6B81E3 Q47641500-F73EBE3B-5038-4423-8663-98F8DE0DDD1E Q48566835-C4848390-C42B-4648-8BF0-CB6207E381EB Q51650326-B070D677-DA1A-4FCF-B47C-F30CCA53F140 Q51899232-4D0A54C4-1C74-4AF3-9DDA-3F15251E82AE Q55265441-61FBD706-2027-4639-84BF-63809CBA80CC Q55419634-7A303622-E709-4B4E-9950-BB0481CD2B41 Q55425729-73E8E001-D1F8-4CC6-A65C-128CFE208C0A Q55512456-98B0E0F0-A4DB-4CE8-93F6-08D9D59462C0

P2860

An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients

http://www.wikidata.org/entity/Q28238050

description

2007 nî lūn-bûn

@nan

2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients

@ast

An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients

@en

An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients

@nl

type

label

An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients

@ast

An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients

@en

An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients

@nl

prefLabel

An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients

@ast

An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients

@en

An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients

@nl

P1433

Q28238050-2CC616B5-F5B6-4106-9498-FD67F9775792

P1476

Q28238050-AE926AB6-92C7-4EA6-834D-8133875AFC92

P2093

Q28238050-05E870C4-58F2-4917-975B-AF910296BA03

Q28238050-1CB1990F-9FD9-4775-8C0E-044DA1970221

Q28238050-39DE5842-2D94-4601-9DD3-6E3B71C93DFA

Q28238050-4CE025AC-506B-46AE-A9EE-C70E4E3E986A

Q28238050-5FD19A99-1E6E-416E-866F-4A07D2402E9C

Q28238050-669DB79F-1F5B-4693-BF02-794598D221C3

Q28238050-6CD90F73-6210-4A7F-AB32-6CE9DF233D18

Q28238050-73E6071D-2D56-441F-BB27-6D295A41EA9B

Q28238050-7F0D634C-6CB4-42DB-BAD4-6B667B80C0E3

Q28238050-8E8D9DE6-9F63-4123-AAA7-06CA8E122B15

P304

Q28238050-58CE356E-6951-48FC-9F44-C3AC31DF2268

P31

Q28238050-8B19957E-F534-4A10-A948-1AEED6C55363

P356

Q28238050-D34E4C06-17F5-4713-B47C-537E5106001F

P407

Q28238050-CFD17269-577A-4C5D-AEA7-8353C1A66FAD

P433

Q28238050-BE3AFDFC-56B0-4ABB-8CA0-60EB1DF3A9CE

P478

Q28238050-6028B776-C197-473B-A6DD-89B6246D7EBF

P50

Q28238050-F8C385EC-1EC5-44C8-804F-81CBF24DEDAB

P577

Q28238050-4BA6D6E9-977B-40AF-AEC9-F1BF84C2A0C6

P5875

Q28238050-AD2D35B2-7B07-4417-9DDE-ACC855FAA32E

P698

Q28238050-2E7A4CF4-B902-4692-87E0-681AF30CB3EF

P921

Q28238050-372DAF5B-E75D-416F-827F-52EDB759748F

P356

J.NMD.2007.05.009

P1433

Neuromuscular Disorders

P1476

An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients

@en

P2093

Allan M Glanzman

http://www.w3.org/2001/XMLSchema#string

Carrie Irvine

http://www.w3.org/2001/XMLSchema#string

Christine Annis

http://www.w3.org/2001/XMLSchema#string

Darryl C De Vivo

http://www.w3.org/2001/XMLSchema#string

Erica Sanborn

http://www.w3.org/2001/XMLSchema#string

Janet Quigley

http://www.w3.org/2001/XMLSchema#string

Jean Flickinger

http://www.w3.org/2001/XMLSchema#string

Jessica M O'Hagen

http://www.w3.org/2001/XMLSchema#string

Maryam Oskoui

http://www.w3.org/2001/XMLSchema#string

Michael P McDermott

http://www.w3.org/2001/XMLSchema#string

P304

693-697

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NMD.2007.05.009

http://www.w3.org/2001/XMLSchema#string

P407

P433

9-10

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6181226

http://www.w3.org/2001/XMLSchema#string

P698

17658255

http://www.w3.org/2001/XMLSchema#string

P921